Carr Douglas 4

4 · Century Therapeutics, Inc. · Filed Feb 4, 2026

AI-generated summary of this filing

Updated Feb 4, 2026

Century Therapeutics (IPSC) SVP Douglas Carr Receives Awards

What Happened

Douglas Carr, SVP Finance & Operations at Century Therapeutics (IPSC), was granted two awards on 2026-02-02: 110,000 restricted stock units (RSUs) and 225,000 derivative awards (stock options). Both grants show an acquisition price of $0.00 (i.e., no cash paid at grant).

Key Details

Transaction date(s) and price(s): 2026-02-02; both awards granted at $0.00 per share.
Award amounts: 110,000 RSUs; 225,000 option/derivative awards.
Vesting (from filing footnotes):
- RSUs: 25% vest on Feb 2, 2027; remaining 75% vest quarterly over the following three years; RSUs will be settled in shares at each vesting date. (F1)
- Options: 25% vest on Feb 2, 2027; remaining 75% vest in 36 equal monthly installments thereafter, subject to continued service. (F2)
Shares owned after the transaction: not specified in the provided filing excerpt.
Filing timeliness: Report filed 2026-02-04 for a 2026-02-02 transaction — appears to be timely (Form 4s are generally due within two business days).

Context

These are compensation grants (award/award-type transactions, code "A") rather than open-market purchases or sales, so they represent standard executive pay/retention incentives rather than an immediate buy/sell signal.
RSUs will convert to actual shares only as they vest; the option awards permit future acquisition of shares according to the stated vesting schedule.

Form 4

Period: 2026-02-02

SVP Finance & Operations

Transactions

Award
Common Stock
[F1]
2026-02-02+110,000→ 514,874 total
Award
Stock Option (right to buy)
[F2]
2026-02-02+225,000→ 225,000 total
Exercise: $1.84Exp: 2036-02-02→ Common Stock (225,000 underlying)

Footnotes (2)

[F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on February 2, 2027, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
[F2]The option vests 25% on February 2, 2027, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.

Signature

/s/ Douglas Carr|2026-02-04

1 file